Effects of Colistin on the Sensory Nerve Conduction Velocity and F-wave in Mice

Basic and Clinical Pharmacology and Toxicology

Volumn 115, Issue 6, 2014, Pages 577-580

  Dai, Chongshan ^a   Tang, Shusheng ^a   Li, Jichang ^b   Wang, Jiping ^c   Xiao, Xilong ^a  

^a CHINA AGRICULTURAL UNIVERSITY   (China)

^b NORTHEAST AGRICULTURAL UNIVERSITY   (China)

^c MONASH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

COLISTIN; ANTIINFECTIVE AGENT;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; APATHY; ARTICLE; ATAXIA; CONTROLLED STUDY; F WAVE; FEMALE; LATENT PERIOD; MOUSE; MUSCLE WEAKNESS; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; SENSORY NERVE CONDUCTION; SENSORY SYSTEM PARAMETERS; ANIMAL; CHEMICALLY INDUCED; DOSE RESPONSE; DRUG EFFECTS; INTRAVENOUS DRUG ADMINISTRATION; NERVE CONDUCTION; SENSORY NERVE CELL;

MUS;

ANIMALS; ANTI-BACTERIAL AGENTS; ATAXIA; COLISTIN; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; INFUSIONS, INTRAVENOUS; MICE; MUSCLE WEAKNESS; NEURAL CONDUCTION; SENSORY RECEPTOR CELLS;

EID: 84925946425     PISSN: 17427835     EISSN: 17427843     Source Type: Journal    
DOI: 10.1111/bcpt.12272     Document Type: Article

References (35)

1. Li J, Nation RL, Turnidge JD, Milne RW, Coulthard K, Rayner CR et al. Colistin: the re-emerging antibiotic for multidrug-resistant Gram-negative bacterial infections. Lancet Infect Dis 2006;6:589-601.
2. Nation RL, Li J. Colistin in the 21st century. Curr Opin Infect Dis 2009;22:535-43.
3. Lim LM, Ly N, Anderson D, Yang JC, Macander L, Jarkowski A 3rd et al. Resurgence of colistin: a review of resistance, toxicity, pharmacodynamics, and dosing. Pharmacotherapy 2010;30:1279-91.
4. Dai C, Li J, Li J. New insight in colistin induced neurotoxicity with the mitochondrial dysfunction in mice central nervous tissues. Exp Toxicol Pathol 2013;65:941-8.
5. Falagas ME, Kasiakou SK. Toxicity of polymyxins: a systematic review of the evidence from old and recent studies. Crit Care 2006;10:R27.
6. Bergen PJ, Li J, Rayner CR, Nation RL. Colistin methanesulfonate is an inactive prodrug of colistin against Pseudomonas aeruginosa. Antimicrob Agents Chemother 2006;50:1953-8.
7. Falagas ME, Kasiakou SK. Colistin: the revival of polymyxins for the management of multidrug-resistant gram-negative bacterial infections. Clin Infect Dis 2005;40:1333-41.
8. Honore PM, Jacobs R, Lochy S, De Waele E, Van Gorp V, De Regt J et al. Acute respiratory muscle weakness and apnea in a critically ill patient induced by colistin neurotoxicity: key potential role of hemoadsorption elimination during continuous venovenous hemofiltration. Int J Nephrol Renovasc Dis 2013;6:107-11.
9. Dai C, Zhang D, Li J. Effect of colistin exposure on calcium homeostasis and mitochondria functions in chick cortex neurons. Toxicol Mech Methods 2013;23:281-8.
10. Wallace SJ, Li J, Nation RL, Rayner CR, Taylor D, Middleton D et al. Subacute toxicity of colistin methanesulfonate in rats: comparison of various intravenous dosage regimens. Antimicrob Agents Chemother 2008;52:1159-61.
11. Dai C, Li J, Lin W, Li G, Sun M, Wang F. Electrophysiology and ultrastructural changes in mouse sciatic nerve associated with colistin sulfate exposure. Toxicol Mech Methods 2012;22:592-6.
12. Aygul R, Ulvi H, Karatay S, Deniz O, Varoglu AO. Determination of sensitive electrophysiologic parameters at follow-up of different steroid treatments of carpal tunnel syndrome. J Clin Neurophysiol 2005;22:222-30.
13. Wahby K, Chopra T, Chandrasekar P. Intravenous and inhalational colistin-induced respiratory failure. Clin Infect Dis 2010;50:e38-40.
14. Frigeni B, Piatti M, Lanzani F, Alberti P, Villa P, Zanna C et al. Chemotherapy-induced peripheral neurotoxicity can be misdiagnosed by the National Cancer Institute Common Toxicity scale. J Peripher Nerv Syst 2011;16:228-36.
15. Müller LJ, Gerritsen van der Hoop R, Moorer-van Delft CM, Gispen WH, Roubos EW. Morphological and electrophysiological study of the effects of cisplatin and ORG.2766 on rat spinal ganglion neurons. Cancer Res 1990;50:2437-42.
16. Pourmohammadi N, Alimoradi H, Mehr SE, Hassanzadeh G, Hadian MR, Sharifzadeh M et al. Lithium attenuates peripheral neuropathy induced by paclitaxel in rats. Basic Clin Pharmacol Toxicol 2012;110:231-7.
17. Garnacho-Montero J, Ortiz-Leyba C, Jimenez-Jimenez FJ, Barrero-Almodovar AE, Garcia-Garmendia JL, Bernabeu-Wittel IM et al. Treatment of multidrug-resistant Acinetobacter baumannii ventilator-associated pneumonia (VAP) with intravenous colistin: a comparison with imipenem-susceptible VAP. Clin Infect Dis 2003;36:1111-8.
18. Fisher MA. F-waves-physiology and clinical uses. ScientificWorldJournal 2007;7:144-60.
19. Hort-Legrand C, Noah L, Meriguet E, Mesangeau D. Motor and sensory nerve conduction velocities in Yucatan minipigs. Lab Anim 2006;40:53-7.
20. Dueck MH, Paul M, Sagawe P, Oberthuer A, Wedekind C, Boerner U. Different F-wave recovery after neuromuscular blockade with pancuronium and mivacurium. Anesth Analg 2004;99:1402-7.
21. Fraser JL, Olney RK. The relative diagnostic sensitivity of different F-wave parameters in various polyneuropathies. Muscle Nerve 1992;15:912-8.
22. Bosso JA, Liptak CA, Seilheimer DK, Harrison GM. Toxicity of colistin in cystic fibrosis patients. DICP 1991;25:1168-70.
23. Schmelz M, Schmidt R, Weidner C, Hilliges M, Torebjork HE, Handwerker HO. Chemical response pattern of different classes of C-nociceptors to pruritogens and algogens. J Neurophysiol 2003;89:2441-8.
24. Sandri AM, Landersdorfer CB, Jacob J, Boniatti MM, Dalarosa MG, Falci DR et al. Population pharmacokinetics of intravenous polymyxin B in critically ill patients: implications for selection of dosage regimens. Clin Infect Dis 2013;57:524-31.
25. Garonzik SM, Li J, Thamlikitkul V, Paterson DL, Shoham S, Jacob J et al. Population pharmacokinetics of colistin methanesulfonate and formed colistin in critically ill patients from a multicenter study provide dosing suggestions for various categories of patients. Antimicrob Agents Chemother 2011;55:3284-94.
26. Dudhani RV, Turnidge JD, Coulthard K, Milne RW, Rayner CR, Li J et al. Elucidation of the pharmacokinetic/pharmacodynamic determinant of colistin activity against Pseudomonas aeruginosa in murine thigh and lung infection models. Antimicrob Agents Chemother 2010;54:1117-24.
27. Yamakawa I, Kojima H, Terashima T, Katagi M, Oi J, Urabe H et al. Inactivation of TNF-alpha ameliorates diabetic neuropathy in mice. Am J Physiol Endocrinol Metab 2011;301:E844-52.
28. Landman D, Georgescu C, Martin DA, Quale J. Polymyxins revisited. Clin Microbiol Rev 2008;21:449-65.
29. Spapen H, Jacobs R, Van Gorp V, Troubleyn J, Honore PM. Renal and neurological side effects of colistin in critically ill patients. Ann Intensive Care 2011;1:14.
30. Lin B, Zhang C, Xiao X. Toxicity, bioavailability and pharmacokinetics of a newly formulated colistin sulfate solution. J Vet Pharmacol Ther 2005;28:349-54.
31. Xiao XL, Bin L, Zhang CP. Studies on the injectable solution of colistin sulfate and its pharmacokinetics. Agric Sci China 2003;2:214-21.
32. Johanek LM, Meyer RA, Hartke T, Hobelmann JG, Maine DN, LaMotte RH et al. Psychophysical and physiological evidence for parallel afferent pathways mediating the sensation of itch. J Neurosci 2007;27:7490-7.
33. Mesrati F, Vecchierini MF. F-waves: neurophysiology and clinical value. Neurophysiol Clin 2004;34:217-43.
34. Panayiotopoulos CP, Chroni E. F-waves in clinical neurophysiology: a review, methodological issues and overall value in peripheral neuropathies. Electroencephalogr Clin Neurophysiol 1996;101:365-74.
35. Markou N, Apostolakos H, Koumoudiou C, Athanasiou M, Koutsoukou A, Alamanos I et al. Intravenous colistin in the treatment of sepsis from multiresistant Gram-negative bacilli in critically ill patients. Crit Care 2003;7:R78-83.